Fertility preservation outcomes may differ by cancer diagnosis

Journal of Human Reproductive Sciences

Volumn 7, Issue 2, 2014, Pages 111-118

  Pavone, Mary Ellen ^a   Hirshfeld Cytron, Jennifer ^a,b   Lawson, Angela K ^a   Smith, Kristin ^a   Kazer, Ralph ^a   Klock, Susan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Fertility Centers of Illinois   (United States)

Author keywords

Cancer; cryopreservation; fertility preservation; in vitro fertilization; oncofertility

Indexed keywords

ESTRADIOL; RECOMBINANT CHORIONIC GONADOTROPIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; KRUSKAL WALLIS TEST; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; RANK SUM TEST; TREATMENT OUTCOME;

EID: 84906998119     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.138869     Document Type: Article

References (29)

1. Bleyer A, Barr R. Cancer in young adults 20 to 39 years of age: Overview. Semin Oncol 2009;36:194-206.
2. Schover LR. Patient attitudes toward fertility preservation. Pediatr Blood Cancer 2009;53:281-4.
3. Oktay K, Rodriguez-Wallberg K, Schover L. Preservation of fertility in patients with cancer. N Engl J Med 2009;360:2681.
4. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 2004;22:4174-83.
5. Kim SS. Fertility preservation in female cancer patients: Current developments and future directions. Fertil Steril 2006;85:1-11.
6. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004;10:251-66.
7. Quintero RB, Helmer A, Huang JQ, Westphal LM. Ovarian stimulation for fertility preservation in patients with cancer. Fertil Steril 2010;93:865-8.
8. Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. J Clin Oncol 2008;26:2630-5.
9. Knopman JM, Noyes N, Talebian S, Krey LC, Grifo JA, Licciardi F. Women with cancer undergoing ART for fertility preservation: A cohort study of their response to exogenous gonadotropins. Fertil Steril 2009;91:1476-8.
10. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006;91:3885-90.
11. Michaan N, Ben-David G, Ben-Yosef D, Almog B, Many A, Pauzner D, et al. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients. Eur J Obstet Gynecol Reprod Biol 2010;149:175-7.
12. Robertson AD, Missmer SA, Ginsburg ES. Embryo yield after in vitro fertilization in women undergoing embryo banking for fertility preservation before chemotherapy. Fertil Steril 2011;95:588-91.
13. Quintero RB, Helmer A, Huang JQ, Westphal LM. Fertility preservation in female cancer patients. Fertil Steril 2005;84:S70-1.
14. Klock SC, Zhang JX, Kazer RR. Fertility preservation for female cancer patients: Early clinical experience. Fertil Steril 2010;94:149-55.
15. Domingo J, Guillén V, Ayllón Y, Martínez M, Muñoz E, Pellicer A, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril 2012;97:930-4.
16. Dittrich R, Maltaris T, Hoffmann I, Oppelt PG, Beckmann MW, Mueller A. Fertility preservation in cancer patients. Minerva Ginecol 2010;62:63-80.
17. Dittrich R, Lotz L, Mueller A, Hoffmann I, Wachter DL, Amann KU, et al. Oncofertility: Combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval. Reprod Biol Endocrinol 2013;11:19.
18. Almog B, Azem F, Gordon D, Pauzner D, Amit A, Barkan G, et al. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation. Fertil Steril 2012;98:957-60.
19. Pavone MH, Lawon A, Smith K, Klock S. ART outcomes may differ by cancer diagnosis. Reprod Sci 2012;19 Suppl 3:337A.
20. Padilla SL, Garcia JE. Effect of maternal age and number of in vitro fertilization procedures on pregnancy outcome. Fertil Steril 1989;52:270-3.
21. Barton SE, Missmer SA, Berry KF, Ginsburg ES. Female cancer survivors are low responders and have reduced success compared with other patients undergoing assisted reproductive technologies. Fertil Steril 2012;97:381-6.
22. Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, et al. Impact of cancer therapies on ovarian reserve. Fertil Steril 2012;97:134-40.e1.
23. Pavone ME, Innes J, Hirshfeld-Cytron J, Kazer R, Zhang J. Comparing thaw survival, implantation and live birth rates from cryopreserved zygotes, embryos and blastocysts. J Hum Reprod Sci 2011;4:23-8.
24. Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril 2007;88:657-64.
25. Friedler S, Koc O, Gidoni Y, Raziel A, Ron-El R. Ovarian response to stimulation for fertility preservation in women with malignant disease: A systematic review and meta-analysis. Fertil Steril 2012;97:125-33.
26. de Bree E, Makrigiannakis A, Askoxylakis J, Melissas J, Tsiftsis DD. Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 2010;101:534-42.
27. Kroman N, Mouridsen HT. Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer. Breast 2003;12:516-21.
28. Azim HA Jr, Santoro L, Pavlidis N, Gelber S, Kroman N, Azim H, et al. Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studies. Eur J Cancer 2011;47:74-83.
29. Oktay K, Kim JY, Barad D, Babayev SN. Association of BRCA1 mutations with occult primary ovarian insufficiency: A possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 2010;28:240-4.